Cataract Clinical Trial
— CORTCOOfficial title:
Comparison of Operating Room Toric Placement Tools, CALLISTO Eye vs. Wavetec AnalyzOR (CORTCO)
NCT number | NCT06216067 |
Other study ID # | MCS12112021 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | December 14, 2021 |
Est. completion date | July 21, 2023 |
Verified date | January 2024 |
Source | Chesapeake Eyecare and Laser Center, LLC |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The goal of this clinical trial is to evaluate two separate operating room cataract measuring tools in predicting the residual astigmatism (prediction error) in patients with corneal astigmatism. The main question it aims to answer is: Show the refractive predictability comparing the use of Operating Room cataract toric lens placement tools against the standard manual technique. Participants will be implanted with the TECNIS Toric II IOL Lens Model ZCU; the second eye, if applicable, is to be implanted within 45 days of the first-eye surgery. Researchers will compare two Operating Room cataract lens placement tools: the Zeiss CALLISTO vs. the Wavetec AnalyzOR to determine refractive predictability.
Status | Completed |
Enrollment | 36 |
Est. completion date | July 21, 2023 |
Est. primary completion date | July 21, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 55 Years to 87 Years |
Eligibility | Inclusion Criteria: - Unilateral or bilateral cataract extraction with single piece hydrophobic acrylic posterior capsular intraocular lens correcting astigmatism. - Clear intraocular media other than cataract. - Willing and able to complete all required postoperative visits. - Able to comprehend and sign a statement of informed consent in English. Exclusion Criteria: - Ocular disease or pathology that, in the opinion of the Investigator, will affect the post-operative visual acuity and manifest refraction. - Prior intraocular or corneal refractive surgery, corneal transplant, or retinal detachment. |
Country | Name | City | State |
---|---|---|---|
United States | Chesapeake Eye Care and Laser Center, LLC | Annapolis | Maryland |
Lead Sponsor | Collaborator |
---|---|
Chesapeake Eyecare and Laser Center, LLC | Carl Zeiss Meditec, Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Diopters of Residual Cylinder | Diopters of Residual Cylinder at Month 1 with an upper boundary and lower boundary of +0.50 D and - 0.50 D | 1 Month postoperatively from implantation of intraocular lens | |
Secondary | Accuracy of Residual Astigmatism (Predictive Error) | Residual Astigmatism of +/- 0.25 D or less, +/- 0.75 D or less, +/- 1.00 or less | Month 1 | |
Secondary | Refractive predictability of the IOL (absolute difference between MRSE and target MRSE) | MRSE within 0.25, 0.50, 0.75, 1.00 of target | Month 1 | |
Secondary | Uncorrected Distance Visual Acuities Achieved - Snellen | Achievement of UCDVA of 20/20, 20/25, 20/30, 20/40 or better | Month 1 | |
Secondary | Procedure and Operating Room Time | Suction on (start of LenSx), treatment time of LenSx in seconds, Suction off (end of LenSx) | Procedure time (up to 2 minutes) | |
Secondary | Operating Room Time | Start and end time of matching reference image to microscope image, start time-primary incision, beginning of Phaco, end of Phaco, CDE (Combined Diffused Energy) Total, Start and end time of phakic power calculation, start and end time of toric positioning, end time of procedure | Operating Room Time (up to 30 minutes) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
Completed |
NCT03356847 -
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
|
N/A | |
Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A |